A 12‑week, randomized, double‑blind, parallel-group, dose-ranging, placebo-controlled efficacy, safety and tolerability study of ThykamineTM rectal enema to treat patients with active mild-to-moderate distal ulcerative colitis.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Thykamine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 03 Jul 2017 New trial record